NCT01262989View on ClinicalTrials.gov

SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin

PHASE1CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

January 4, 2010

Primary Completion Date

January 26, 2010

Study Completion Date

January 26, 2010

Conditions

Prostatic Hyperplasia

Interventions

DRUG

Test formulation

tamsulosin hydrochloride 0,4 mg (Synthon BV)

DRUG

Reference formulation

tamsulosin 0,4 mg (Boehringer Ingelheim)

Trial Locations (1)

Unknown

GSK Investigational Site, Campinas

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01262989 - SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin | Biotech Hunter | Biotech Hunter